NEUOHUMORAL AND IMMUNOLOGICAL DISORDERS IN PATIENTS WITH Q-MYOCARDIAL INFARCTION WITH METABOLIC SYNDROME
DOI:
https://doi.org/10.21856/j-PEP.2014.2.04Keywords:
Q-myocardial infarction, metabolic syndrome, tumor necrosis factor-α, C-reactive protein, plasminogen activator inhibitor-1Abstract
It was studied neurohumoral and immunoinflammatory disorders in 184 patients with Q-myocardial infarction (153 with metabolic syndrome and 31 without metabolic syndrome). It was found that acute period of Q-myocardial infarction in patients with metabolic syndrome is associated with a decrease in serum insulin-like growth factor and activation of a range of neurohormonal and immunoinflammatory factors: C-reactive protein, interleukin-1α, interleukin-6, tumor necrosis factor-α, endothelin-1, plasminogen activator inhibitor-1, which have close correlations with the components of the metabolic syndrome.
References
Medyko-social’ni aspekty hvorob systemy krovoobigu: analityko-statystychnyj posibnyk, za red. VM. Kovalenka, VM.Kornac’kogo, Kyi’v, 2010:146 p.
Kornac’kyj VM, Reven’ko IL. Ukr Kardiol Zhurn 2008; 1:121-124.
Mitchenko EI. Ukr Kardiol Zhurn 2007; 5:74-80.
Berezin OJe. Ukr Med Chasopys 2007; 2(58):20-23.
Man’kovs’kyj BM. Nova Medycyna 2005; 1:38-39.
Gorshuns’ka MJu, Karachencev JuI, Krasova NS, et al. Probl Endokryn Patologii’ 2008; 2:5-10.
Souza JRM, Olivera RT, Blotta MNSL, Coelho OR. Arg Bras Cardiol 2008; 90(2):2016-2021.
Alessi MC. Aterosclerosis, Thrombosis, and Vascular Biology 2006; 26:2200.
Kovalenko VM. Ukr Kardiol Zhurn 2007; 5:8-11.
Nian M, Lee P, Khaper N, Liu P. Circ Res 2004; 94:1543-1553.
Fischer F, Schulte H, Mohan S, et al. Endocrinology (Oxf), 2004; 61:595-602
Dabek J, Mazurek U, Gasior Z, et al. Int J Cardiol 2006; 111:275-279.
Pitsavos C, Panagiotakos DB, Chrysohoou C, et al. Eur J Cardiovasc Prev Rehabil 2005; 12(2):151-158.
Kravchun NA. Visnyk HNU im. VM. Karazina 2006; 738:99-103.